KPWS
CHRS icon

Kestra Private Wealth Services’s Coherus Oncology CHRS Stock Holding History

Kestra Private Wealth Services’s Portfolio CHRS Stock Details CHRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-20,000
Closed -$28.4K – 1794
2025
Q4 		$28.4K Buy
+20,000
New +$29.1K ﹤0.01% 1697

Other funds holding CHRS

TGY2IT
Timothy G. Youngquist 2020 Irrevocable Trust Fort Myers, Florida $530M AUM 95.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return

Kestra Private Wealth Services's CHRS Position: Q1 2026 in Review

Kestra Private Wealth Services sold out of Coherus Oncology (CHRS) in Q1 2026, closing a stake of 20,000 shares — an estimated $28.4K sold.

Kestra Private Wealth Services first reported a position in CHRS in Q4 2025 and held it in 1 quarter. The position peaked at $28.4K in Q4 2025. 158 funds tracked by Wall St. Rank hold CHRS as of Q1 2026.

  • Kestra Private Wealth Services reported no remaining Coherus Oncology position as of Q1 2026 after selling out during the quarter.
  • Kestra Private Wealth Services sold 20,000 Coherus Oncology shares in Q1 2026, an estimated $28.4K.
  • Kestra Private Wealth Services first reported a position in Coherus Oncology in Q4 2025 and held it in 1 quarter.
  • Kestra Private Wealth Services's Coherus Oncology position peaked at $28.4K in Q4 2025.
  • 158 funds tracked by Wall St. Rank held Coherus Oncology as of Q1 2026.

Based on Kestra Private Wealth Services's 13F filing for Q1 2026, filed 20 Apr 2026.